Tag: regulatory affairs

GCP Considerations for AI-Supported Trial Tools and Algorithms GCP Considerations for AI-Supported Trial Tools and Algorithms The integration of artificial intelligence (AI) into clinical trials is rapidly changing the landscape of clinical research. As AI-supported tools and algorithms become more prevalent, especially in decentralized clinical trial settings, it’s crucial for clinical operations, regulatory affairs, and…

Read More “GCP Considerations for AI-Supported Trial Tools and Algorithms” »

Hybrid Site and Remote Models: GCP Risks and Mitigation Strategies Hybrid Site and Remote Models: GCP Risks and Mitigation Strategies As clinical trials evolve to accommodate advancements in technology and patient accessibility, hybrid site and remote models have become increasingly prominent. This article is a step-by-step guide focused on Good Clinical Practice (GCP) compliance in…

Read More “Hybrid Site and Remote Models: GCP Risks and Mitigation Strategies” »

Inspection Readiness for Digital and Decentralized Clinical Programs Inspection Readiness for Digital and Decentralized Clinical Programs In the evolving landscape of clinical trials, digital and decentralized methodologies are gaining prominence. As clinical operations, regulatory affairs, and medical affairs professionals, ensuring inspection readiness for these innovative approaches is essential. This comprehensive guide outlines the steps necessary…

Read More “Inspection Readiness for Digital and Decentralized Clinical Programs” »

Vendor and Technology Partner Governance in Virtual Trials Vendor and Technology Partner Governance in Virtual Trials In the evolving landscape of clinical research, ensuring compliance with regulatory standards while utilizing the benefits of technology is paramount. This article provides a comprehensive step-by-step guide on Vendor and Technology Partner Governance in the setting of virtual trials,…

Read More “Vendor and Technology Partner Governance in Virtual Trials” »

Documenting Digital Workflows and Data Flows in Protocol and TMF Documenting Digital Workflows and Data Flows in Protocol and TMF In the evolving landscape of clinical research, where digital solutions are becoming increasingly prominent, it is crucial for clinical professionals to effectively document the workflows and data flows involved in clinical trials. This guide outlines…

Read More “Documenting Digital Workflows and Data Flows in Protocol and TMF” »

Monitoring and Source Verification in Decentralized Trial Models In recent years, the landscape of clinical research has undergone a transformative shift, particularly with the rise of decentralized trial models. The adaptation of digital technologies in clinical trials offers promising benefits and efficiency gains. However, implementing effective monitoring and source verification practices within decentralized models presents…

Read More “Monitoring and Source Verification in Decentralized Trial Models” »

Participant Safety and Signal Detection in Highly Digital Studies Participant Safety and Signal Detection in Highly Digital Studies Introduction to Participant Safety in Digital Clinical Trials The rise of highly digital studies, including decentralized clinical trials (DCTs), has transformed the landscape of translational clinical research, demanding a fresh perspective on participant safety and signal detection….

Read More “Participant Safety and Signal Detection in Highly Digital Studies” »

Managing BYOD, Wearables and Sensor Data in Compliance With GCP Managing BYOD, Wearables and Sensor Data in Compliance With GCP In the evolving landscape of clinical research, the integration of Bring Your Own Device (BYOD) strategies and wearable technologies presents unique opportunities and challenges in data management and compliance. This comprehensive guide is geared towards…

Read More “Managing BYOD, Wearables and Sensor Data in Compliance With GCP” »

Investigator Responsibilities When Care Is Delivered Remotely Investigator Responsibilities When Care Is Delivered Remotely The shift towards remote care in clinical trials has fundamentally transformed the way that healthcare is delivered to trial participants. As clinical operations, regulatory affairs, and medical affairs professionals in the US, UK, and EU navigate this landscape, it’s essential to…

Read More “Investigator Responsibilities When Care Is Delivered Remotely” »